Cornerstone Capital Management Holdings’s Albany Molecular Research Inc AMRI Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-6,700	Closed	-$148K	–	1366
2014 Q3	$148K	Sell	6,700 -7,400	-52%	-$152K	﹤0.01%	1135
2014 Q2	$283K	Buy	14,100 +2,000	+17%	+$33.9K	﹤0.01%	1073
2014 Q1	$225K	Sell	12,100 -5,000	-29%	-$68.8K	﹤0.01%	1098
2013 Q4	$172K	Buy	17,100 +1,871	+12%	+$22.6K	﹤0.01%	1064
2013 Q3	$196K	Buy	15,229 +5,829	+62%	+$71.7K	﹤0.01%	1056
2013 Q2	$112K	Buy	+9,400	New	+$102K	﹤0.01%	1105

Other funds holding AMRI

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Cornerstone Capital Management Holdings's AMRI Position: Q4 2014 in Review

Cornerstone Capital Management Holdings sold out of Albany Molecular Research Inc (AMRI) in Q4 2014, closing a stake of 6,700 shares — an estimated $148K sold.

Cornerstone Capital Management Holdings first reported a position in AMRI in Q2 2013 and held it in 6 quarters. The position peaked at $283K in Q2 2014. 132 funds tracked by Wall St. Rank hold AMRI as of Q4 2014.

Cornerstone Capital Management Holdings reported no remaining Albany Molecular Research Inc position as of Q4 2014 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 6,700 Albany Molecular Research Inc shares in Q4 2014, an estimated $148K.
Cornerstone Capital Management Holdings first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 6 quarters.
Cornerstone Capital Management Holdings's Albany Molecular Research Inc position peaked at $283K in Q2 2014.
132 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2014.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2014, filed 13 Feb 2015.